Míchael Landthaler

Míchael Landthaler's AcademicInfluence.com Rankings

Míchael Landthaler

Medical

#1763

World Rank

#2137

Historical Rank

Dermatology

#25

World Rank

#37

Historical Rank

medical Degrees

Míchael Landthaler

Philosophy

#5310

World Rank

#8072

Historical Rank

Logic

#2610

World Rank

#3623

Historical Rank

philosophy Degrees

Download Badge

Medical
Philosophy

Why Is Míchael Landthaler Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Míchael Landthaler's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Dermoscopy of pigmented skin lesions: results of a consensus meeting via the Internet. (2003) (1099)
The ABCD rule of dermatoscopy. High prospective value in the diagnosis of doubtful melanocytic skin lesions. (1994) (786)
A first prospective randomized controlled trial to decrease bacterial load using cold atmospheric argon plasma on chronic wounds in patients (2010) (568)
Oxygen in acute and chronic wound healing (2010) (515)
Successful and safe use of 2 min cold atmospheric argon plasma in chronic wounds: results of a randomized controlled trial (2012) (384)
Skin ageing (2011) (353)
Plasma applications in medicine with a special focus on dermatology (2011) (350)
The role of singlet oxygen and oxygen concentration in photodynamic inactivation of bacteria (2007) (342)
Differential gene expression of Eph receptors and ephrins in benign human tissues and cancers. (2004) (327)
Cytokines, chemokines and growth factors in wound healing (2012) (325)
Wound healing in the 21st century. (2010) (318)
Plasma medicine: possible applications in dermatology (2010) (301)
Singlet oxygen generation by UVA light exposure of endogenous photosensitizers. (2006) (281)
Intense pulsed light (IPL): A review (2010) (261)
Postzygotic HRAS and KRAS mutations cause nevus sebaceous and Schimmelpenning syndrome (2012) (256)
Improvement of early recognition of lentigo maligna using dermatoscopy. (2000) (253)
Photo-oxidative killing of human colonic cancer cells using indocyanine green and infrared light (1999) (246)
Mosaicism of activating FGFR3 mutations in human skin causes epidermal nevi. (2006) (201)
Oncogenic PIK3CA mutations occur in epidermal nevi and seborrheic keratoses with a characteristic mutation pattern (2007) (194)
Hyper-IgE syndromes. (1989) (193)
Photodynamic therapy in dermatology – an update (2005) (183)
Fast and effective skin ablation with an Er:YAG laser: Determination of ablation rates and thermal damage zones (1997) (175)
The impact of the pH value on skin integrity and cutaneous wound healing (2010) (175)
Hair removal with the long pulsed Nd:YAG laser: A prospective study with one year follow‐up (2002) (173)
Indocyanine green: intracellular uptake and phototherapeutic effects in vitro. (1997) (171)
2D luminescence imaging of pH in vivo (2011) (169)
Epidermal damage and limited coagulation depth with the flashlamp-pumped pulsed dye laser: a histochemical study. (1995) (167)
Overexpression of monocyte chemoattractant protein 1 in systemic sclerosis: role of platelet-derived growth factor and effects on monocyte chemotaxis and collagen synthesis. (2001) (166)
Induction of Hsp90 protein expression in malignant melanomas and melanoma metastases (2004) (164)
Cold atmospheric argon plasma treatment may accelerate wound healing in chronic wounds: Results of an open retrospective randomized controlled study in vivo (2013) (155)
Photostability and thermal stability of indocyanine green. (1998) (152)
Braun-Falco´s Dermatology (2009) (150)
Photodynamic therapy in dermatology: state‐of‐the‐art (2010) (148)
Photodynamic therapy with topical application of 5-aminolevulinic acid in the treatment of actinic keratoses: an initial clinical study. (1996) (148)
Antiangiogenetic therapy with pioglitazone, rofecoxib, and metronomic trofosfamide in patients with advanced malignant vascular tumors (2003) (144)
PENETRATION POTENCY OF TOPICAL APPLIED δ‐AMINOLEVULINIC ACID FOR PHOTODYNAMIC THERAPY OF BASAL CELL CARCINOMA * (1994) (140)
Indocyanine green (ICG) and laser irradiation induce photooxidation (2000) (136)
Incidence of Health Problems Associated with Tattooed Skin: A Nation-Wide Survey in German-Speaking Countries (2010) (135)
Q‐switch laser and tattoo pigments: First results of the chemical and photophysical analysis of 41 compounds (2000) (128)
Benign symmetric lipomatosis Launois-Bensaude. Report of ten cases and review of the literature. (1987) (125)
Tattoo Pigments are Cleaved by Laser Light—The Chemical Analysis In Vitro Provide Evidence for Hazardous Compounds¶ (2004) (122)
Direct detection of singlet oxygen generated by UVA irradiation in human cells and skin. (2007) (121)
Randomized placebo‐controlled human pilot study of cold atmospheric argon plasma on skin graft donor sites (2013) (120)
Photodynamic inactivation of multi‐resistant bacteria (PIB) – a new approach to treat superficial infections in the 21st century (2011) (117)
Topical photodynamic therapy for localized scleroderma. (2000) (116)
Foreign body granulomas caused by polymethylmethacrylate microspheres: successful treatment with allopurinol. (2003) (116)
Simultaneous photographing of oxygen and pH in vivo using sensor films. (2011) (108)
Long‐pulse dye laser for photodynamic therapy: Investigations in vitro and in vivo (1999) (105)
Side‐effects and complications of flashlamp‐pumped pulsed dye laser therapy of port‐wine stains. A prospective study (1996) (102)
Keratinocyte‐derived cytokines after photodynamic therapy and their paracrine induction of matrix metalloproteinases in fibroblasts (2004) (102)
Phacomatosis pigmentokeratotica is caused by a postzygotic HRAS mutation in a multipotent progenitor cell. (2013) (102)
Adverse Reactions after Tattooing: Review of the Literature and Comparison to Results of a Survey (2013) (101)
Tattoo inks contain polycyclic aromatic hydrocarbons that additionally generate deleterious singlet oxygen (2009) (101)
Topical photodynamic therapy in dermatology. (1996) (100)
Modern tattoos cause high concentrations of hazardous pigments in skin (2008) (98)
Mycophenolate mofetil and cyclosporin treatment for recalcitrant pyoderma gangrenosum (1997) (98)
Luminescent Dual Sensors Reveal Extracellular pH-Gradients and Hypoxia on Chronic Wounds That Disrupt Epidermal Repair (2014) (98)
Effects of Cold Atmospheric Plasma (CAP) on ß-Defensins, Inflammatory Cytokines, and Apoptosis-Related Molecules in Keratinocytes In Vitro and In Vivo (2015) (97)
Benefit of elective lymph node dissection in subgroups of melanoma patients. Results of a multicenter study of 3616 patients (1993) (95)
In vitro and in vivo comparison of two different light sources for topical photodynamic therapy (2006) (95)
Time-resolved investigations of singlet oxygen luminescence in water, in phosphatidylcholine, and in aqueous suspensions of phosphatidylcholine or HT29 cells. (2005) (95)
Comparison of the 308‐nm excimer laser and a 308‐nm excimer lamp with 311‐nm narrowband ultraviolet B in the treatment of psoriasis (2005) (93)
Overexpression of Lerk-5/Eplg5 messenger RNA: a novel marker for increased tumorigenicity and metastatic potential in human malignant melanomas. (1998) (91)
Long‐term results in the treatment of childhood hemangioma with the flashlamp‐pumped pulsed dye laser: An evaluation of 617 cases (2001) (91)
IgE-mediated anaphylactic reaction induced by succinate ester of methylprednisolone. (2002) (90)
Association of early malignant melanoma with nevocytic nevi (1989) (89)
A possible new incoherent lamp for photodynamic treatment of superficial skin lesions. (1994) (89)
The -2518 promotor polymorphism in the MCP-1 gene is associated with systemic sclerosis. (2005) (89)
In vivo confocal scanning laser microscopy in dermatology (2007) (89)
Laser therapy of childhood haemangiomas (1995) (87)
Histopathological diagnosis of onychomycosis by periodic acid–Schiff‐stained nail clippings (2003) (87)
Multiple oncogenic mutations and clonal relationship in spatially distinct benign human epidermal tumors (2010) (85)
Theoretical and experimental analysis of the luminescence signal of singlet oxygen for different photosensitizers. (2007) (85)
Neodymium-YAG laser therapy for vascular lesions. (1986) (85)
Loss of EphB6 expression in metastatic melanoma. (2003) (85)
Expression profile of Eph receptors and ephrin ligands in human skin and downregulation of EphA1 in nonmelanoma skin cancer (2006) (85)
Wavelength dependency of photodynamic effects after sensitization with 5-aminolevulinic acid in vitro and in vivo. (1995) (84)
Keratinocytic epidermal nevi are associated with mosaic RAS mutations (2012) (84)
High frequency of FGFR3 mutations in adenoid seborrheic keratoses. (2006) (84)
RBP2‐H1/JARID1B is a transcriptional regulator with a tumor suppressive potential in melanoma cells (2007) (81)
Quality-switched ruby laser treatment of solar lentigines and Becker's nevus: a histopathological and immunohistochemical study. (1997) (81)
Retinoblastoma-binding protein 2-homolog 1: a retinoblastoma-binding protein downregulated in malignant melanomas (2005) (80)
Indocyanine green and laser light for the treatment of AIDS-associated cutaneous Kaposi's sarcoma. (1998) (80)
Activation of the PI3K/AKT Pathway in Merkel Cell Carcinoma (2012) (80)
Influence of 5-aminolevulinic acid and red light on collagen metabolism of human dermal fibroblasts. (2003) (80)
Tattooing of skin results in transportation and light‐induced decomposition of tattoo pigments – a first quantification in vivo using a mouse model (2010) (79)
Progression and NSAID-induced apoptosis in malignant melanomas are independent of cyclooxygenase II (2001) (78)
Abels, W. Bäumler, Quantum Yield of Triplet Formation for Indocyanine Green, (1997) (78)
Recurrence of port‐wine stains after treatment with the flashlamp‐pumped pulsed dye laser (2000) (78)
Congenital multiple plaquelike glomus tumors. (1990) (77)
A three-year experience with the argon laser in dermatotherapy. (1984) (76)
Cutaneous amyloidoses and systemic amyloidoses with cutaneous involvement. (2010) (76)
In situ expression patterns of melanoma‐inhibiting activity (MIA) in melanomas and breast cancers (1999) (76)
Improvement of monitoring of melanocytic skin lesions with the use of a computerized acquisition and surveillance unit with a skin surface microscopic television camera. (1996) (76)
Photodynamic therapy in dermatology. (2006) (76)
Long‐term dermoscopic follow‐up of melanocytic naevi: clinical outcome and patient compliance (2003) (75)
Effects of light fractionation and different fluence rates on photodynamic therapy with 5-aminolaevulinic acid in vivo (2003) (74)
Skin signs in diabetes mellitus (2012) (74)
Both the flashlamp‐pumped dye laser and the long‐pulsed tunable dye laser can improve results in port‐wine stain therapy (2001) (74)
Selective photothermolysis of blood vessels following flashlamp-pumped pulsed dye laser irradiation: in vivo results and mathematical modelling are in agreement. (2005) (73)
A randomized two‐sided placebo‐controlled study on the efficacy and safety of atmospheric non‐thermal argon plasma for pruritus (2013) (72)
Epidermodysplasia verruciformis treated using topical 5‐aminolaevulinic acid photodynamic therapy (1999) (72)
[Cutaneous amyloidoses]. (1990) (71)
A Seven-Marker Signature and Clinical Outcome in Malignant Melanoma: A Large-Scale Tissue-Microarray Study with Two Independent Patient Cohorts (2012) (70)
Orofacial Granulomatosis as the Initial Presentation of Crohn’s Disease in an Adolescent (2003) (68)
Ephrin-B2 overexpression enhances integrin-mediated ECM-attachment and migration of B16 melanoma cells. (2005) (68)
Optimal parameters for the treatment of leg veins using Nd:YAG lasers at 1064 nm (2006) (66)
Treatment of oral lichen planus with the 308‐nm UVB excimer laser—early preliminary results in eight patients (2003) (65)
Granuloma pyogenicum as a complication of flashlamp-pumped pulsed dye laser. (1994) (65)
[The dermatoscope. A simplification of epiluminescent microscopy of pigmented skin changes]. (1990) (64)
Increase in telomerase activity during progression of melanocytic cells from melanocytic naevi to malignant melanomas (1999) (64)
Inhibitory effects of 13-cis-retinoic acid on human sebaceous glands (2004) (64)
Photochemical cleavage of a tattoo pigment by UVB radiation or natural sunlight (2007) (63)
p53‐protein and Ki‐67‐antigen expression are both reliable biomarkers of prognosis in thick stage I nodular melanomas of the skin (1997) (63)
Non-oncologic indications for ALA-PDT (2002) (63)
Willingness to pay and time trade‐off: sensitive to changes of quality of life in psoriasis patients? (2003) (63)
SKIN SURFACE MICROSCOPY (1989) (63)
Wells’ syndrome associated with idiopathic hypereosinophilic syndrome (1997) (63)
Comparison of the maximum coagulation depth in human skin for different types of medical lasers (1987) (62)
Heat shock protein 70 membrane expression and melanoma‐associated marker phenotype in primary and metastatic melanoma (2003) (62)
Effects of argon, dye, and Nd: YAG lasers on epidermis, dermis, and venous vessels (1986) (62)
Variable pulsed light is less painful than light‐emitting diodes for topical photodynamic therapy of actinic keratosis: a prospective randomized controlled trial (2007) (61)
FGFR3 mutations in seborrheic keratoses are already present in flat lesions and associated with age and localization (2007) (60)
Cyclooxygenase 2 (COX2) and Peroxisome Proliferator-Activated Receptor Gamma (PPARG) Are Stage-Dependent Prognostic Markers of Malignant Melanoma (2009) (59)
Willingness to pay and time trade‐off: useful utility indicators for the assessment of quality of life and patient satisfaction in patients with port wine stains (2002) (59)
Laser Therapy of Venous Lakes (Bean‐Walsh) and Telangiectasias (1984) (59)
Identification of differentially expressed genes in models of melanoma progression by cDNA array analysis: SPARC, MIF and a novel cathepsin protease characterize aggressive phenotypes (2003) (58)
Antiproliferative and proapoptotic effects of rapamycin and celecoxib in malignant melanoma cell lines. (2008) (58)
BRAF and RAS Mutations in Sporadic and Secondary Pyogenic Granuloma. (2016) (57)
Black tattoo inks are a source of problematic substances such as dibutyl phthalate (2011) (57)
Role of Lasers and Photodynamic Therapy in the Treatment of Cutaneous Malignancy (2001) (57)
Laser therapy of verrucous epidermal naevi (1993) (57)
Neodymium‐YAG Laser for hemangiomas and vascular malformations – long term results (2005) (56)
Photodynamic therapy and fluorescence diagnosis of skin cancers. (2002) (56)
Dermatoscopy of "dysplastic nevi": a beacon in diagnostic darkness. (2006) (56)
Aplasia cutis congenita after exposure to methimazole: a causal relationship? (1995) (56)
Correlations Between Light Penetration into Skin and the Therapeutic Outcome Following Laser Therapy of Port-wine Stains (2002) (56)
LASER CORNER: Laser Therapy of Bowenoid Papulosis and Bowen's Disease (1986) (56)
Variable pulsed light is less painful than light-emitting diodes for topical photodynamic therapy of actinic keratosis: a prospective randomized controlled trial. (2007) (55)
Photo-isomerisation, triplet formation, and photo-degradation dynamics of indocyanine green solutions (1999) (54)
Activation of the PI3K/AKT signalling pathway in non‐melanoma skin cancer is not mediated by oncogenic PIK3CA and AKT1 hotspot mutations (2010) (54)
Targeted combined anti-inflammatory and angiostatic therapy in advanced melanoma: a randomized phase II trial (2007) (53)
2D luminescence imaging of physiological wound oxygenation (2011) (53)
Photodynamic Therapy in Dermatology – an Update 2008 (2008) (53)
Successful treatment of cutaneous sarcoidosis using topical photodynamic therapy. (2002) (53)
Novel pharmacological approaches in the treatment of psoriasis (2005) (52)
Successful treatment of hydroxyethyl starch‐induced pruritus with topical capsaicin (1994) (52)
Split‐face‐study using two different light sources for topical PDT of actinic keratoses:non‐inferiority of the LED system (2007) (52)
Permanent make‐up colorants may cause severe skin reactions (2010) (52)
Topical photodynamic therapy with porphyrin precursors--assessment of treatment-associated pain in a retrospective study. (2009) (51)
Aesthetic effects of topical photodynamic therapy (2010) (51)
Tumor cell growth fractions in human malignant melanomas and the correlation to histopathologic tumor grading. (1989) (51)
Evaluation of a multicentre study of synchronous application of narrowband ultraviolet B phototherapy (TL‐01) and bathing in Dead Sea salt solution for psoriasis vulgaris (2000) (50)
Disappointing results and low tolerability of photodynamic therapy with topical 5‐aminolaevulinic acid in psoriasis. A randomized, double‐blind phase I/II study (2006) (50)
Transcutaneous pO2 imaging during tourniquet‐induced forearm ischemia using planar optical oxygen sensors (2008) (49)
Health risks of tattoo colors (2008) (48)
Establishment of an extraction method for the recovery of tattoo pigments from human skin using HPLC diode array detector technology. (2006) (48)
FGFR3 and PIK3CA mutations are involved in the molecular pathogenesis of solar lentigo (2009) (48)
A sprayable luminescent pH sensor and its use for wound imaging in vivo (2012) (47)
Adjuvant Photodynamic Therapy Does Not Prevent Recurrence of Condylomata Acuminata After Carbon Dioxide Laser Ablation—A Phase III, Prospective, Randomized, Bicentric, Double‐Blind Study (2009) (47)
The effects of intense pulsed light (IPL) on blood vessels investigated by mathematical modeling (2007) (46)
9-Acetoxy-2,7,12,17-tetrakis-(beta-methoxyethyl)-porphycene (ATMPn), a novel photosensitizer for photodynamic therapy: uptake kinetics and intracellular localization. (1996) (46)
Identification of new genes associated with melanoma (2011) (46)
Re-expression of the retinoblastoma-binding protein 2-homolog 1 reveals tumor-suppressive functions in highly metastatic melanoma cells. (2006) (46)
Split‐face comparison of intense pulsed light with short‐ and long‐pulsed dye lasers for the treatment of port‐wine stains (2010) (44)
Laser therapy of vascular lesions (2006) (44)
Generalized eczema in an 18‐month‐old boy due to phenoxyethanol in DPT vaccine (1998) (44)
Loss of expression or mutations in the p73 tumour suppressor gene are not involved in the pathogenesis of malignant melanomas (1998) (44)
Simulations on the selectivity of 5-aminolaevulinic acid-induced fluorescence in vivo. (1998) (44)
Late irradiation damage to the skin caused by soft X-ray radiation therapy of cutaneous tumors. (1995) (43)
Acquired lymphangioma of the vulva: palliative treatment by means of laser vaporization carbon dioxide. (1990) (43)
Metastatic signet-ring cell melanoma in a patient with an unknown primary tumor. Histologic, immunohistochemical, and ultrastructural findings. (1992) (43)
Carbon dioxide laser therapy of a widespread epidermal nevus (1995) (42)
Azo Pigments and a Basal Cell Carcinoma at the Thumb (2007) (42)
Rapid response of IgA pemphigus of subcorneal pustular dermatosis type to treatment with isotretinoin. (2000) (42)
Discrimination between gene expression patterns in the invasive margin and the tumour core of malignant melanomas (2003) (42)
Expression of RANTES in biopsies of skin and upper gastrointestinal tract from patients with systemic sclerosis (1999) (42)
High‐dose intravenous immune globulin is also effective in linear IgA disease (2000) (42)
Investigation of toxicity and mutagenicity of cold atmospheric argon plasma (2017) (42)
Ephrin-B2 is differentially expressed in the intestinal epithelium in Crohn's disease and contributes to accelerated epithelial wound healing in vitro. (2005) (41)
Quality of life in health care of non‐melanoma skin cancer – results of a pilot study (2011) (41)
Simultaneous occurrence of folliculitis decalvans capillitii in identical twins (2000) (41)
Leg telangiectasia treatment with a 1.5 ms pulsed dye laser, ice cube cooling of the skin and 595 vs 600 nm: Preliminary results (1998) (40)
Antiangiogenic therapy with pioglitazone, rofecoxib, and trofosfamide in a patient with endemic kaposi sarcoma. (2004) (40)
Activating mutations in the RAS/mitogen-activated protein kinase signaling pathway in sporadic trichoblastoma and syringocystadenoma papilliferum. (2015) (40)
Applications of laser light of low power density. Experimental and clinical investigations. (1986) (40)
Fibroadenoma of the Axilla (2005) (40)
Photodynamic therapy in dermatology (2006) (40)
Mu opioid receptor knockdown in the substantia nigra/ventral tegmental area by synthetic small interfering RNA blocks the rewarding and locomotor effects of heroin (2009) (39)
A first prospective randomized controlled trial on the efficacy and safety of synchronous balneophototherapy vs. narrow‐band UVB monotherapy for atopic dermatitis (2011) (39)
Contact-free inactivation of Trichophyton rubrum and Microsporum canis by cold atmospheric plasma treatment. (2013) (39)
The Effect of Different Spot Sizes on the Efficacy of Hair Removal Using a Long‐Pulsed Diode Laser (2002) (39)
Spectrum of FGFR3 mutations in multiple intraindividual seborrheic keratoses. (2007) (39)
Black Tattoos Entail Substantial Uptake of Genotoxicpolycyclic Aromatic Hydrocarbons (PAH) in Human Skin and Regional Lymph Nodes (2014) (38)
A new star on the H2O2rizon of wound healing? (2011) (38)
Metastasis of a malignant melanoma 2 years after carbon dioxide laser treatment of a pigmented lesion: case report and review of the literature. (2005) (38)
Tamoxifen Treatment of Oligozoospermia (2009) (37)
Argon Laser Therapy of Verrucous Nevi (1984) (37)
Management of Split-Thickness Donor Sites With Synthetic Wound Dressings: Results of a Comparative Clinical Study (2010) (37)
Severe erythema anulare centrifugum-like psoriatic drug eruption induced by terbinafine. (1995) (37)
Unilateral localized basaliomatosis: treatment with topical photodynamic therapy after application of 5-aminolevulinic acid. (1995) (36)
Topical application of a first porphycene dye for photodynamic therapy – penetration studies in human perilesional skin and basal cell carcinoma (1997) (36)
Acute mercury intoxication with lichenoid drug eruption followed by mercury contact allergy and development of antinuclear antibodies. (1992) (36)
Impact of Age and Body Site on Adult Female Skin Surface pH (2012) (36)
FGFR3 and PIK3CA mutations in stucco keratosis and dermatosis papulosa nigra (2010) (36)
Adjuvant therapy with pegylated interferon alfa-2b (36 months) versus low-dose interferon alfa-2b (18 months) in melanoma patients without macrometastatic nodes: an open-label, randomised, phase 3 European Association for Dermato-Oncology (EADO) study. (2013) (36)
Detection of differentially regulated genes in keratinocytes by cDNA array hybridization: Hsp27 and other novel players in response to artificial ultraviolet radiation. (2001) (35)
Overexpression and hyperphosphorylation of retinoblastoma protein in the progression of malignant melanoma (2005) (35)
RNA fingerprinting displays UVB-specific disruption of transcriptional control in human melanocytes. (1997) (35)
The Effects of Laser Light on Sperm Motility and Velocity in vitro (2009) (35)
The decrease of pigment concentration in red tattooed skin years after tattooing (2011) (35)
Munich method of micrographic surgery for basal cell carcinomas: 5-year recurrence rates with life-table analysis. (2004) (34)
[The menstrual cycle and the skin]. (2005) (34)
Low incidence of EGFR and HRAS mutations in cutaneous squamous cell carcinomas of a German cohort (2011) (34)
Ehlers-Danlos type VIII (2000) (34)
Indocyanine green‐augmented diode laser treatment of port‐wine stains: clinical and histological evidence for a new treatment option from a randomized controlled trial (2012) (34)
FGFR3, PIK3CA and RAS mutations in benign lichenoid keratosis (2012) (34)
Hair Removal Using a 5‐msec Long‐Pulsed Ruby Laser (2000) (34)
Methylthioadenosine phosphorylase represents a predictive marker for response to adjuvant interferon therapy in patients with malignant melanoma (2009) (34)
Variable pulse frequency-doubled Nd:YAG laser versus flashlamp-pumped pulsed dye laser in the treatment of port wine stains. (2003) (34)
Eruptive Multiple Lentigo-Maligna-Like Lesions in a Patient Undergoing Chemotherapy with an Oral 5-Fluorouracil Prodrug for Metastasizing Colorectal Carcinoma: A Lesson for the Pathogenesis of Malignant Melanoma? (2002) (34)
Phototherapy of Psoriasis: Comparative Experience of Different Phototherapeutic Approaches (2001) (34)
Deficiency of a novel retinoblastoma binding protein 2-homolog is a consistent feature of sporadic human melanoma skin cancer. (1999) (33)
Ex vivo quality-switched ruby laser irradiation of cutaneous melanocytic lesions: persistence of S-100-, HMB-45- and Masson-positive cells. (1997) (33)
Ephrin-B reverse signaling induces expression of wound healing associated genes in IEC-6 intestinal epithelial cells. (2005) (33)
BRAF and RAS Mutations in Sporadic and Secondary Pyogenic Granuloma. (2016) (32)
Intradermal buried vertical mattress suture as sole skin closure: evaluation of 149 cases. (2000) (32)
Treatment of benign, semimalignant, and malignant skin tumors with the Nd:YAG laser (1985) (32)
Laser treatment of congenital vascular malformations. (1990) (32)
Discrimination of melanocytic tumors by cDNA array hybridization of tissues prepared by laser pressure catapulting. (2004) (32)
Detection of melanoma cells in the blood of melanoma patients by melanoma-inhibitory activity (MIA) reverse transcription-PCR. (1999) (32)
Cowpox and a cat (2005) (32)
Somatic FGFR3 and PIK3CA mutations are present in familial seborrhoeic keratoses (2008) (32)
[MIA ("melanoma inhibitory activity"). Biological functions and clinical relevance in malignant melanoma]. (1998) (31)
Pityriasis rubra pilaris: A clinico-pathological and therapeutic study with special reference to histochemistry, autoradiography, and electron microscopy (2004) (31)
Confocal laser scanning microscopy—evaluation of native tissue sections in micrographic surgery (2009) (31)
Targeting T Cells to Hit B Cells: Successful Treatment of Cutaneous Plasmacytosis with Topical Pimecrolimus (2006) (31)
Treatment of digital mucous cysts with a carbon dioxide laser. (1999) (31)
Exacerbation of Pityriasis Rubra Pilaris under Efalizumab Therapy (2007) (30)
Discoid Lupus Erythematosus and Lupus Profundus in Childhood: A Report of Two Cases (2003) (30)
Photodynamic Inactivation of Staphylococci with 5-Aminolaevulinic Acid or Photofrin (1999) (30)
Early Recurrence of Eruptive Vellus Hair Cysts after Er: YAG Laser Therapy Case Report and Review of the Literature (2005) (29)
Melanoma inhibitory activity (MIA), a serological marker of malignant melanoma. (2001) (29)
Excisional biopsy as the first therapeutic procedure versus primary wide excision of malignant melanoma (1989) (29)
Topical 5-aminolevulinic acid for photodynamic therapy of basal cell carcinoma. Evaluation of stratum corneum permeability in vitro (1996) (29)
Chapter 1 History of photodynamic therapy in dermatology (2001) (29)
Management of erosive lichen planus with topical tacrolimus and recurrence secondary to metoprolol (2005) (29)
Primary Cutaneous Cryptococcosis and Secondary Antigenemia in a Patient with Long-Term Corticosteroid Therapy (2005) (29)
Computer assisted learning in medicine: a long-term evaluation of the ‘Practical Training Programme Dermatology 2000’ (2003) (29)
Therapy of vascular lesions in the head and neck area by means of argon, Nd: YAG, CO2 and flashlamp-pumped pulsed dye lasers. (1995) (29)
Amiodarone-induced pigmentation resolves after treatment with the Q-switched ruby laser. (1999) (29)
Development of a targeted risk‐group model for skin cancer screening based on more than 100 000 total skin examinations (2012) (29)
Nd:YAG laser hyperthermia in the treatment of recalcitrant verrucae vulgares (Regensburg's technique). (1994) (28)
[BK-mole syndrome]. (1979) (28)
FGFR3 mutation affects cell growth, apoptosis and attachment in keratinocytes. (2010) (28)
Photoepilation with a diode laser vs. intense pulsed light: a randomized, intrapatient left‐to‐right trial (2013) (28)
Laser and IPL treatment of port-wine stains: therapy options, limitations, and practical aspects (2011) (28)
[Postoperative adjuvant therapy with interferon alfa-2B following laser surgery of condylomata acuminata]. (1990) (28)
Effects of Mometasone Furoate on Human Keratinocytes and Fibroblasts in vitro (1998) (27)
Detection of activated complement complex C5b-9 and complement receptor C5a in skin biopsies of patients with systemic sclerosis (scleroderma). (2000) (27)
A randomized clinical trial in psoriasis: synchronous balneophototherapy with bathing in Dead Sea salt solution plus narrowband UVB vs. narrowband UVB alone (TOMESA‐study group) (2011) (27)
Recommendation for Laser and Intense Pulsed Light (IPL) Therapy in Dermatology (2007) (27)
Bowen's disease on porokeratotic eccrine ostial and dermal duct nevus. (2007) (27)
Whole-body UVB irradiation during allogeneic hematopoietic cell transplantation is safe and decreases acute graft-versus-host disease. (2012) (27)
Phacomatosis pigmentokeratotica: Speckled-Lentiginous Nevus in Association with Nevus sebaceus (1998) (27)
Fractional carbon dioxide laser resurfacing of rhytides and photoaged skin – A prospective clinical study on patient expectation and satisfaction (2015) (27)
Treatment of diffuse plane xanthoma of the face with the Erbium:YAG laser. (2001) (26)
Lichen striatus (blaschkitis) following varicella infection (2006) (26)
Nonablative wrinkle reduction: treatment results with a 585-nm laser. (2002) (26)
Clonality of Basal Cell Carcinoma Arising in an Epidermal Nevus (2008) (26)
Assessment of microsatellite instability and loss of heterozygosity in sporadic keratoacanthomas (1999) (26)
Recurring Mistakes in Tattoo Removal (2008) (26)
Fumaric acid esters therapy: a new treatment modality in pityriasis rubra pilaris? (2005) (26)
Pityriasis rubra pilaris successfully treated with adalimumab (2010) (26)
Differences in efficacy between intention‐to‐treat and per‐protocol analyses for patients with psoriasis vulgaris and atopic dermatitis: clinical and pharmacoeconomic implications (2001) (26)
Hereditary haemorrhagic telangiectasia treated by pulsed neodymium:yttrium-aluminium-garnet (Nd:YAG) laser (1,064 nm) (2008) (26)
The absence of BRAF, FGFR3, and PIK3CA mutations differentiates lentigo simplex from melanocytic nevus and solar lentigo. (2009) (25)
[Mali's acroangiodermatitis (pseudo-Kaposi) in paralyzed legs]. (1988) (25)
Lupus vulgaris caused by Mycobacterium bovis ssp. caprae (2005) (25)
A HCl/alcohol formulation increased 5‐aminolevulinic acid skin distribution using an ex vivo full thickness porcine skin model (2008) (25)
Fatty acids and vitamins generate singlet oxygen under UVB irradiation (2012) (25)
Does smoking influence the efficacy of bath‐PUVA therapy in chronic palmoplantar eczema? (2000) (25)
Pseudo-Kaposi's sarcoma occurring after placement of arteriovenous shunt. A case report with DNA content analysis. (1989) (25)
Laser therapy of skin tumors. (1995) (24)
Laser surgical planning with magnetic resonance imaging-based 3-dimensional reconstructions for intralesional Nd:YAG laser therapy of a venous malformation of the neck. (2001) (24)
Photothermolysis of blood vessels using indocyanine green and pulsed diode laser irradiation in the dorsal skinfold chamber model (2007) (24)
Evidence‐based topical management of chronic wounds according to the T.I.M.E. principle (2013) (24)
Photosensitization of human skin cell lines by ATMPn (9-acetoxy-2,7,12,17-tetrakis-(beta-methoxyethyl)-porphycene) in vitro: mechanism of action. (1999) (24)
Comparing cold‐air analgesia, systemically administered analgesia and scalp nerve blocks for pain management during photodynamic therapy for actinic keratosis of the scalp presenting as field cancerization: a randomized controlled trial (2015) (24)
Cyclophosphamide–dexamethasone pulsed therapy for treatment of recalcitrant necrobiotic xanthogranuloma with paraproteinemia and ocular involvement (2005) (24)
Anaphylaxis to buckwheat (2001) (24)
An Internet-based survey on characteristics of laser tattoo removal and associated side effects (2014) (24)
The effectiveness of low-dose intravenous immunoglobulin in chronic urticaria. (2000) (24)
PTCH mutations are not mainly involved in the pathogenesis of sporadic trichoblastomas. (2007) (24)
[Skin changes in newborn infants in the first 5 days of life]. (2000) (23)
Optimizing treatment parameters for hair removal using long-pulsed Nd:YAG-lasers (2004) (23)
Elevated MIA serum levels are of relevance for management of metastasized malignant melanomas: results of a German multicenter study. (2000) (23)
Crohn's disease: an important differential diagnosis of granulomatous skin diseases. (2009) (23)
Photodynamic therapy using intense pulsed light for treating actinic keratoses and photoaged skin of the dorsal hands: a randomized placebo‐controlled study (2017) (23)
Animal Experiments on Light-Induced Woundhealing (1982) (23)
[Photodynamic therapy of skin tumors]. (1993) (23)
[Treatment of circumscribed lymphangiomas with the argon laser]. (1982) (23)
Laser treatment of childhood haemangioma: progress or not? (2002) (23)
Bullous congenital ichthyosiform erythroderma: safe and effective topical treatment with calcipotriol ointment in a child. (2003) (22)
Transient and Partial Effect of High-Dose Intravenous Immunoglobulin in Polyarteritis nodosa (2001) (22)
Percutaneous and combined percutaneous and intralesional Nd:YAG-laser therapy for vascular malformations. (1999) (22)
[Morphologic studies in the treatment of nevus flammeus with argon laser]. (1983) (22)
Severe contact urticaria to guar gum included as gelling agent in a local anaesthetic (2005) (22)
Elastosis perforans serpiginosa‐like pseudoxanthoma elasticum in a child with severe Moya Moya disease (2005) (22)
Microsatellite instability in malignant melanomas. (2001) (22)
Fractional carbon dioxide laser resurfacing of rhytides and photoageing: a prospective study using profilometric analysis (2014) (22)
Benign Degos' disease developing during pregnancy and followed for 10 years. (2002) (21)
Antiproliferative effects of rapamycin and celecoxib in angiosarcoma cell lines. (2010) (21)
Tissue microarray analysis of methylthioadenosine phosphorylase protein expression in melanocytic skin tumors. (2006) (21)
Effects of Two Retinoids in Animal Experiments and After Clinical Application in Acne Patients: 13-cis-Retinoic Acid Ro 4-3780 and Aromatic Retinoid Ro 10-9359 (1981) (21)
Off‐label use of fumarate therapy for granulomatous and inflammatory skin diseases other than psoriasis vulgaris: a retrospective study (2012) (21)
[The laser in dermatology]. (2012) (21)
Dead Sea treatment - principle for outpatient use in atopic dermatitis: safety and efficacy of synchronous balneophototherapy using narrowband UVB and bathing in Dead Sea salt solution. (2002) (21)
Progressive hyperpigmentation and generalized lentiginosis without associated systemic symptoms: a rare hereditary pigmentation disorder in south-east Germany. (2003) (21)
Analysis of gene expression patterns in systemic sclerosis fibroblasts using RNA arbitrarily primed-polymerase chain reaction for differential display. (2007) (21)
Ataxia-telangiectasia (Louis-Bar syndrome) associated with ulcerating necrobiosis lipoidica. (1994) (21)
Thymoma, myasthenia gravis, eruptions of pemphigus vulgaris and a favourable course of relapsing melanoma: an immunological puzzle (2006) (21)
Loss of dipeptidyl peptidase IV immunostaining discriminates malignant melanomas from deep penetrating nevi (2006) (21)
Seborrheic dermatitis and atopic eczema in human immunodeficiency virus infection. (1990) (20)
[Malignant atrophic papulosis (Köhlmeier-Degos disease)]. (1989) (20)
Laser therapy of bowenoid papulosis and Bowen's disease. (1986) (20)
Ehlers-Danlos type VIII. Review of the literature. (2000) (20)
Leg ulcers and abscesses caused by Serratia marcescens. (2008) (20)
Role of Laser Therapy in Dermatology – Clinical Aspects (2004) (20)
A Randomized Controlled Trial to Optimize Indocyanine Green‐Augmented Diode Laser Therapy of Capillary Malformations (2013) (20)
Gene expression profile changes between melanoma metastases and their daughter cell lines: implication for vaccination protocols. (2005) (20)
Recurrent inflammation in incontinentia pigmenti of a seven-year-old child. (1995) (20)
Ehlers-Danlos syndrome type VIII with severe periodontitis and apical root resorption after orthodontic treatment. (2000) (20)
[Treatment of naevi flammei with the argon laser]. (1987) (20)
Low Incidence of Oncogenic EGFR, HRAS, and KRAS Mutations in Seborrheic Keratosis (2014) (20)
Ataxia Telangiectasia-Mutated Gene Is a Possible Biomarker for Discrimination of Infiltrative Deep Penetrating Nevi and Metastatic Vertical Growth Phase Melanoma (2007) (20)
Sporadic Bazex–Dupré–Christol‐like Syndrome: Early Onset Basal Cell Carcinoma, Hypohidrosis, Hypotrichosis, and Prominent Milia (2000) (20)
Multivariate DNA cytometry discriminates between Spitz nevi and malignant melanomas because large polymorphic nuclei in Spitz nevi are not aneuploid. (1996) (19)
Progressive Disseminated Essential Telangiectasia and Erythrosis Interfollicularis Colli as Examples for Successful Treatment with a High-Intensity Flashlamp (2008) (19)
Tolerance of desirudin in a patient with generalized eczema after intravenous challenge with heparin and a delayed-type skin reaction to high and low molecular weight heparins and heparinoids. (2000) (19)
Evaluation of the long pulsed high fluence alexandrite laser therapy of leg telangiectasia (2002) (19)
Cyclosporin combined with methotrexate in two patients with recalcitrant subacute cutaneous lupus erythematosus (2011) (19)
Antiangiogenic therapy in metastatic prostate carcinoma complicated by cutaneous lupus erythematodes. (2006) (19)
Cutaneous Pseudolymphoma Induced by Cimicifuga racemosa (2006) (18)
Indocyanine green‐augmented diode laser therapy of telangiectatic leg veins: A randomized controlled proof‐of‐concept trial (2012) (18)
Reactive Perforating Collagenosis after Disseminated Zoster (2001) (18)
Results of nonablative wrinkle reduction with a 1,450‐nm diode laser: Difficulties in the assessment of “subtle changes” (2005) (18)
Dermatitis Herpetiformis Presenting as Digital Petechiae (2012) (17)
Adjuvant therapy with pegylated interferon alfa-2b (36 months) versus low-dose interferon alfa-2b (18 months) in melanoma patients without macro-metastatic nodes: EADO trial. (2010) (17)
Development of two malignant melanomas during administration of levodopa. (1985) (17)
Naevi spili, Café-au-lait spots and melanocytic naevi aggregated alongside Blaschko's lines, with a review of segmental melanocytic lesions. (1998) (17)
Teledermatoscopy in daily routine--results of the first 100 cases. (2003) (17)
Treatment of severe localized scleroderma by plasmapheresis report of three cases (1995) (17)
Primary Anetoderma in Children: Report of Two Cases and Literature Review (1996) (17)
Indocyanine green‐augmented diode laser therapy vs. long‐pulsed Nd:YAG (1064 nm) laser treatment of telangiectatic leg veins: a randomized controlled trial (2013) (16)
UV-A-provoked localized bullous pemphigoid. (1994) (16)
Effects of 13-cis-Retinoic Acid on Sebaceous Glands in Humans (1981) (16)
[Physical and biological principles of the use of lasers in dermatology (author's transl)]. (1981) (16)
Congenital Cartilaginous Rests of the Neck (Wattles) (2005) (16)
Experience with non-ablative fractional photothermolysis with a dual-mode laser device (1,440/1,320 nm): no considerable clinical effect on hypertrophic/acne scars and facial wrinkles (2011) (16)
Treatment of Old World Cutaneous Leishmaniasis with Intralesionally Injected Meglumine Antimoniate Using a Dermojet Device (2003) (16)
Gene Expression Profiling of Melanocytes following Q-Switched Ruby Laser Irradiation (2007) (16)
Selective photothermolysis of hair follicles by normal-mode ruby laser treatment. (1998) (15)
[Adenoid cystic sweat gland carcinoma. A clinicopathologic and immunohistochemical study]. (1994) (15)
A potential predictive marker for response to interferon in malignant melanoma (2007) (15)
CHILD syndrome with mild skin lesions: histopathologic clues for the diagnosis (2014) (15)
Lentigo Maligna and Lentigo Maligna Melanoma in Young Adults (2004) (15)
Laser thermal therapy of benign skin tumours: Review and update (2011) (15)
Prevalence of piercing in a German population. (2008) (15)
Nd:YAG laser therapy of an oral verrucous leukoplakia. (1989) (15)
Bullous Malignant Melanoma: An Unusual Differential Diagnosis of a Hemorrhagic Friction Blister (2003) (15)
Kyrle Disease and Acquired Perforating Collagenosis Secondary to Chronic Renal Failure and Diabetes Mellitus (2011) (15)
Lipodermatosclerosis: successful treatment with danazol. (2005) (14)
Differentiation between malignant melanomas and benign melanocytic nevi by computerized DNA cytometry of imprint specimens * (1994) (14)
Effect of low energy laser on the growth and regeneration of capillaries (1990) (14)
Ultrastructural discrimination between malignant melanomas and benign nevocytic nevi using high-resolution image and multivariate analyses. (1991) (14)
Skin alterations due to illegal drug abuse (2011) (14)
Granulomatous jellyfish dermatitis (2007) (14)
Dysplastic Melanocytic Nevi of the Lower Leg: Sex- and Site-Specific Histopathology (2010) (14)
Acral verrucous malignant melanoma in an immunosuppressed patient after kidney transplantation. (1991) (14)
Phototoxic reactions in healthy volunteers following photodynamic therapy with methylaminolevulinate cream or with cream containing 5‐aminolevulinic acid: a phase II, randomized study (2009) (14)
Treatment of Atopic Dermatitis and Impact on Quality of Life (2012) (14)
Teledermatology - the requirements of dermatologists in private practice (2000) (14)
A rare allergy to a polyether dental impression material (2012) (14)
[Post-zoster granuloma anulare]. (1989) (13)
[Malignant melanoma in childhood and adolescence]. (1991) (13)
Cutaneous ulcerations on hands and heels secondary to long-term hydroxyurea treatment. (2004) (13)
Arsenic-induced skin tumors treated with topical photodynamic therapy after application of 5-aminolevulinic acid (1995) (13)
[Controversy in dermatology--laser therapy and melanocytic nevi]. (2004) (13)
Treatment of leg veins with indocyanine green and lasers investigated with mathematical modelling (2011) (13)
Willingness-To-Pay and Time-Trade-Off: Useful Utilities in Patients with Psoriasis vulgaris? (2000) (13)
[The CO2 laser in dermatotherapy--use and indications]. (1988) (13)
[Ichthyosis vulgaris, growth retardation, hair dysplasia, tooth abnormalities, immunologic deficiencies, psychomotor retardation and resorption disorders. Case report of 2 siblings]. (1981) (13)
The Venous Nevus: A Distinct Vascular Malformation Suggesting Mosaicism (2007) (13)
[Topical photodynamic therapy in treatment of superficial skin tumors]. (1995) (13)
Absence of BRAF and HRAS mutations in eruptive Spitz naevi (2011) (12)
[Use of the TDF factor in soft roentgen radiotherapy]. (1989) (12)
The Use of Photodynamic Therapy for Skin Cancer (1998) (12)
The Impact of 10% α-Hydroxy Acid Emulsion on Skin pH (2011) (12)
[Soft radiotherapy of lip cancer]. (1981) (12)
[Argon laser therapy of sebaceous adenoma]. (1982) (12)
["Smoldering systemic mastocytosis. "Successful therapy with cladribine]. (2004) (12)
Biomodulatory metronomic therapy in stage IV melanoma is well‐tolerated and may induce prolonged progression‐free survival, a phase I trial (2015) (12)
[Treatment of port-wine stains with the flash lamp pumped dye laser. 5 years of clinical experience]. (2001) (12)
Malignant melanoma in human immunodeficiency virus type 2 infection. (1991) (12)
Relapsing polychondritis presenting as cutaneous polyarteritis nodosa (1993) (12)
Mixed Capillary/Lymphatic Malformation with Coexisting Port‐Wine Stain: Treatment Utilizing 3D MRI and CT‐Guided Sclerotherapy (2000) (12)
Regarding the multilayer technique for treatment of PWS. (2001) (11)
Sodium benzoate-induced acute leukocytoclastic vasculitis with unusual clinical appearance. (1999) (11)
Airborne contact dermatitis due to chloroacetamide in wall paint (2001) (11)
[Spinocellular cancers and myxoid atypical fibroxanthoma of an actinically damaged burn scar]. (1991) (11)
[Therapeutic use of lasers in dermatology]. (1981) (11)
[Acne conglobata-like exacerbation of acne vulgaris following administration of anabolic steroids and vitamin B complex-containing preparations]. (1990) (11)
Immunohistochemical demonstration of myoepithelial cells in sweat gland carcinomas. (1994) (11)
Dose comparison of tropisetron (Navoban) 5 mg and 10 mg orally in the prophylaxis of dacarbazine-induced nausea and emesis. (1994) (11)
Amyloid in skin and brain: What′s the link? (2010) (11)
Naevus marginatus revisited: a combined organoid and nonorganoid epidermal naevus caused by HRAS mutation (2013) (11)
Characteristic but unfamiliar--the cowpox infection, transmitted by a domestic cat. (1996) (11)
Fractional carbon dioxide laser resurfacing of skin grafts: long‐term results of a prospective, randomized, split‐scar, evaluator‐blinded study (2018) (10)
[Graft-versus-Host Disease (GvHD) - an update : Part 1: Pathophysiology, clinical features and classification of GvHD]. (2011) (10)
[Malignant melanoma with unknown primary tumor. Case reports of 12 patients with overview]. (1981) (10)
[Anaphylactic reaction following hair bleaching]. (2005) (10)
Melanoma Promotion after Photodynamic Therapy of a Suspected Bowen’s Disease Lesion (2009) (10)
[Treatment of therapy-resistant verruca vulgaris with long-pulsed tunable dye laser]. (2001) (10)
Recommendations for medical and aesthetic treatment of the skin using laser or intense pulsed light (IPL) systems (2008) (10)
Adjuvant therapy of high-risk malignant melanoma patients with gamma interferon. (1989) (10)
Port wine stain laser therapy and the computer-assisted modeling of vessel coagulation using the finite elements method (2005) (10)
Familial primary localized cutaneous amyloidosis with an oncostatin M receptor‐β mutation, Pro694Leu (2013) (10)
Superior vena cava syndrome: an important differential diagnosis in patients with facial edema. (2001) (10)
[Malignant infiltrating blue nevus of the plaque type. Case report and literature review]. (1995) (10)
Disseminated superficial porokeratosis induced by furosemide. (2000) (9)
Q-switched ruby laser application is safe and effective for the management of actinic lentigo (topical glycolic acid is not). (1996) (9)
Immunohistochemical demonstration of myoepithelial cells in sweat gland carcinomas (1994) (9)
[Q-switched ruby laser in dermatologic therapy. Use and indications]. (1997) (9)
Elimination of a community-acquired methicillin-resistant Staphylococcus aureus infection in a nurse with atopic dermatitis. (2005) (9)
Outcome survey of insect venom allergic patients with venom immunotherapy in a rural population (2008) (9)
[Fluorescence-assisted biopsy of basal cell carcinomas]. (2000) (9)
[Therapy-resistant pyoderma gangrenosum--treatment with mycophenolate mofetil and cyclosporine A]. (1999) (9)
Branched filaments no fungus, ovoid bodies no bacteria: Two unusual cases of mycetoma. (2003) (9)
Hemangiomas of infancy and childhood (2007) (9)
Traditional tattooing of the gingiva: successful treatment with the argon laser. (1990) (9)
Nonradioactive arbitrarily primed polymerase chain reaction: a novel technique for detecting genetic defects in skin tumors. (1996) (9)
[Elastolysis of the mid-dermis and annular elastolytic giant cell granuloma: different stages in the clinical spectrum of dermal elastolysis? Case report and review of the literature]. (1997) (8)
Nevus Marginatus: A Distinct Type of Epidermal Nevus or Merely a Variant of Nevus Sebaceus? (2008) (8)
Are dermatologists in private practice interested in teledermatological services? (1999) (8)
A 5-year experience with laser therapy in dermatology. (1986) (8)
Comparison of erbium: YAG and carbon dioxide laser for the treatment of facial rhytides. (1999) (8)
[Lentigo of the glans penis]. (1989) (8)
Identification of an oncostatin M receptor mutation associated with familial primary cutaneous amyloidosis (2009) (8)
[Pseudo-Kaposi sarcoma in Prader-Labhart-Willi syndrome]. (1991) (8)
Diet‐induced pigmented purpuric dermatosis (2014) (8)
[Multiple primary malignant tumors in patients with malignant melanoma of the skin]. (1992) (8)
Severe neurological disabilities after complete remission of advanced malignant melanoma following fotemustine therapy in combination with total brain irradiation. (2002) (8)
Comparison of Two Absorbable Monofilament Polydioxanone Threads in Intradermal Buried Sutures (2005) (8)
[Familial-hereditary malignant melanoma (author's transl)]. (1979) (8)
[Treatment of hypertrophic scars and keloids with Orgotein]. (1984) (8)
Effectiveness of 4% disodium cromoglycate in the treatment of disseminated pyoderma gangrenosum. (1996) (8)
[Experiences with the antiestrogen tamoxifen in the therapy of oligozoospermia]. (1981) (8)
[Sebaceous gland hyperplasia as a side effect of cyclosporin A. Treatment with the CO2 laser]. (1998) (8)
[The disease picture of verruciform xanthoma]. (1988) (8)
[Cutaneous wound healing. Therapeutic interventions]. (2010) (7)
[Malignant melanomas of the vulva]. (2008) (7)
[The number and distribution of nevus cell nevi in patients with malignant melanoma]. (1989) (7)
[Extracutaneous malignant melanomas: clinical aspects and biology]. (1992) (7)
Fundamentals of laser light interaction with human tissue, especially in the cardiovascular system. (1988) (7)
Acquired tufted angioma in association with a complex cutaneous vascular malformation (1999) (7)
Generalized Solar Lentigines in a Patient with a History of Radon Exposure (2010) (7)
Lubrol-RAFTs in Melanoma Cells: A Molecular Platform for Tumor-Promoting Ephrin-B2–Integrin-β1 Interaction (2007) (7)
[Multiple eccrine spiradenomas in a linear nevoid pattern]. (1990) (7)
[Allopurinol in treatment of cutaneous sarcoidosis]. (1998) (7)
Isomorphic phenomenon: adverse effect after epilation with the long-pulsed ruby laser. (2000) (7)
Deposits of paraprotein in small vessels as a cause of skin ulcers in Waldenström's macroglobulinemia (1993) (6)
Aquatic dermatoses (2008) (6)
[Nevi flammei in childhood and adolescence. Treatment with the flashlamp-pumped pulsed dye laser]. (1995) (6)
[The artificial pacemaker erythema]. (1998) (6)
[Ichthyosis vulgaris, deafness, pili torti and tooth abnormalities]. (1978) (6)
[Proliferating tricholemmal tumor]. (1988) (6)
Photosensitization of skin‐derived cell lines by Dimegin [2,4‐di‐(α‐methoxyethyl)‐deuteroporphyrin IX] in vitro (1998) (6)
[Transverse nasal groove. A rare embryological error in nature]. (2001) (6)
Psoriatische Onycho-Pachydermo-Periostitis (2002) (6)
[Laser and cryotherapy of hemangioma in infants in a direct comparison]. (1998) (6)
The Argon Laser in Dermatotherapy (1991) (6)
Eruptive satellite angiomas of the oral mucosa. (1994) (6)
[Porokeratosis Mibelli gigantea: case report and literature review]. (1999) (6)
[The "red melanoma"--a rare form of amelanotic malignant melanoma]. (2004) (6)
[Photochemotherapy with indocyanine green in cutaneous metastases of rectal carcinoma]. (1997) (6)
Dysplastic nevus syndrome. (1987) (6)
Treatment of recalcitrant verrucae vulgares with Nd:YAG laser hyperthermia (Regensburg's technique)-preliminary results in 31 cases (1995) (6)
Follicular mycosis fungoides: variability of a rare entity. (2005) (6)
[Laser therapy for tattoos]. (2006) (5)
[Porokeratotic eccrine ostial and dermal duct naevus (PEODDN)]. (2003) (5)
Laser Therapy of Anogenital Papillomavirus Infections — The View of the Dermatologist (1990) (5)
[Alpha 2 -interferon therapy in metastasizing malignant melanoma]. (2008) (5)
Effective delayed brush treatment of an extensive traumatic tattoo. (2000) (5)
Lubrol-RAFTs in melanoma cells: a molecular platform for tumor-promoting ephrin-B2-integrin-beta1 interaction. (2006) (5)
[Pancreatogenic panniculitis. 2 case reports with a literature review]. (1989) (5)
Topical photodynamic therapy with 5-aminolevulinic acid in the treatment of actinic keratoses: a first clinical study (1996) (5)
[Classification, diagnosis and differential diagnosis of malignant melanomas]. (1986) (5)
[Linear IgA disease with ocular involvement associated with ulcerative colitis]. (2010) (5)
[Roentgen soft radiotherapy of eyelid basaliomas]. (1983) (5)
[Laser therapy. Availability and use]. (1993) (5)
Stroma‐targeted palliative tumor therapy with biomodulators (2006) (5)
[Dye and nickel allergy in the hairdressing salon]. (1981) (5)
[Treatment of zoster, post-zoster pain and herpes simplex recidivans in loco with laser light]. (1983) (5)
Papuloerythroderma Ofuji: Bade-PUVA-Behandlung (1999) (5)
Treatment of Bowen's disease with topical photodynamic therapy (1993) (4)
[Cutis hyperelastica circumscripta. A case report with a morphologic study]. (1984) (4)
[Angiosarcoma of the scalp]. (1988) (4)
[Anorectal malignant melanomas: report on 7 personal cases and 374 cases from the literature. Report of the experiences of a tumor center]. (1985) (4)
Post-traumatic iatrogenic aggravation of eruptive collagenomas in a child. (2006) (4)
[Prosthesis edge nodule and verrucous hyperplasia in leg amputees]. (1997) (4)
[Dermatoses in leg amputees]. (1996) (4)
The CO2 Laser in Dermatotherapy (1991) (4)
Lasers in Dermatology (1991) (4)
[Laser therapy of the skin]. (1995) (4)
[Paraneoplastic Bazex acrokeratosis in adenocarcinoma of the stomach]. (2001) (4)
KRAS, HRAS and EGFR Mutations in Sporadic Sebaceous Gland Hyperplasia. (2016) (4)
[Paralytic abdominal hernia in zoster]. (1979) (4)
[Skin changes with chemotherapy]. (2005) (4)
Tattoo Pigments are Cleaved by Laser Light‐The Chemical Analysis In Vitro Provide Evidence for Hazardous Compounds ¶ (2004) (4)
[Soft-roentgen radiotherapy of induratio penis plastica]. (1983) (4)
Prognostic significance of DNA cytometry in comparison with histologic measurements in malignant melanomas. (1995) (4)
Port-wine stains in childhood and adolescence. Treatment with the flashlamp-pumped pulsed dye laser (1995) (4)
Severe acneiform skin reaction during therapy with erlotinib (Tarceva), an epidermal growth factor receptor (EGFR) inhibitor. (2007) (4)
Spindle Cell Hemangioma (2003) (4)
Distinct profile of the mitochondrial DNA common deletion in benign skin lesions (2011) (3)
[Primary osteoma cutis]. (1988) (3)
[Improving clinical diagnosis of pigmented skin changes in childhood with the dermatoscope]. (1991) (3)
[Interferon-gamma. Therapy of recurrent furunculosis in HIV infections]. (1993) (3)
Dermatology Course 2000: an interactive multimedia dermatology course for students. Programme description and first results. (2003) (3)
Foreign Body Granulomas Caused by Polymethylmethacrylate Microspheres: An Added Perspective—Reply (2003) (3)
[Treatment of superficial varicosities with a flashlamp-pumped pulsed dye laser with 1.5 ms impulse time]. (1998) (3)
[Graft-versus-host disease (GvHD) - an update. Part 2: prognosis and therapy of GvHD]. (2011) (3)
[Skin and eyes]. (2010) (3)
[The ruby laser: can removal of pigmented skin changes with the ruby laser be done by non-physician personnel?]. (1996) (3)
[Necrobiotic xanthogranuloma with eye involvement. Overview and case report]. (1995) (3)
[Cutaneous microdialysis. Use in dermatology]. (2002) (3)
Indocyanine green-augmented diode laser treatment of port wine stains: Clinical and histological evidence for a new treatment option from a randomized controlled trial (RCT) (2012) (3)
[Classification of vascular abnormalities and neoplasms]. (1997) (3)
SKIN PHOTOTOXICITY AFTER INTRAVESICAL INSTILLATION OF 5-AMINOLEVULINIC ACID FOR FLUORESCENCE DIAGNOSIS OF BLADDER CANCER (1999) (3)
[Eruptive melanocytic nevi after chemotherapy]. (1998) (3)
Wavelength-dependent in-vitro and in-vivo photodynamic effects after sensitization with 5-aminolevulinic acid induced protoporphyrin IX (1996) (3)
Laser light of low power density does not influence chemotaxis and collagen synthesis of human dermal fibroblasts (1992) (3)
[Viscerocutaneous hemangiomatosis--the so-called blue-rubber-bleb nevus syndrome]. (1991) (3)
[Steroid-induced scabies norvegica]. (1997) (3)
[Treatment of pediatric hemangiomas with the flashlamp-pumped pulsed dye laser]. (1996) (3)
[Therapeutic strategies for cutaneous sarcoidosis]. (2005) (3)
Topical application of a novel porphycene dye for photodynamic therapy: penetration studies in human perilesional skin and basal cell carcinoma (1996) (3)
Dosedependent photodynamic effects of 9-acetoxy-2,7,12,17-tetrakis(\-methoxyethyl)-porphycene in vitro (1997) (3)
Skin rejuvenation with intense pulsed light. (2010) (3)
[Ectopic parotid tissue. An usual differential cervical cystic tumor diagnosis]. (2000) (3)
Alterations of acyl-neuraminic acids on T-lymphocytes in cases of melanoma (1988) (3)
„Smouldering systemic mastocytosis“ (2004) (3)
First results from the Patient's Anastrozole Compliance to Therapy (PACT) program evaluating the influence of a standardized information service on compliance in postmenopausal women with early breast cancer (EBC). (2010) (3)
Comprar Braun-Falco´s Dermatology | Michael Landthaler | 9783540293125 | Springer (2008) (2)
[Truss-induced macular amyloidosis]. (2001) (2)
[New developments in laser therapy]. (2012) (2)
A survey among dermatologists in practice about teledermatology. (2003) (2)
Laser therapy in dermatology (1999) (2)
Sweet’s syndrome masquerading as figurate erythema (2012) (2)
Improved prognosis for defined risk groups by lymph node dissection. Long-term study of 3616 melanoma patients (1994) (2)
ADAMS: A PC based acquisition, data management, and surveillance system for pigmented skin lesions (PSL) using dermatoscopy (1994) (2)
[Late metastasis in malignant melanoma of the skin]. (1989) (2)
Clinical and Histological Examinations on Laser Therapy in Dermatology (1982) (2)
[On the color black]. (1998) (2)
[Sugar beet pollen allergy as a rare occupational disease]. (1996) (2)
[Treatment of a herpetic gingivostomatitis with acyclovir (Zovirax) in a female patient in the last trimester of pregnancy]. (1985) (2)
A 12-month-old boy with impaired pigmentation. Diagnosis: nevus depigmentosus. (2009) (2)
[Zosteriform pigmented purpura of Schamberg: case report and differential diagnosis of zosteriform skin lesions]. (2004) (2)
In vivo autoradiography and planimetry of epidermis in psoriatics under PUVA-therapy (2004) (2)
From its beginnings to future directions: a look back on 10 years Journal of the German Society of Dermatology (2012) (2)
Molecular genetic analysis excludes implantation metastasis of basal cell carcinomas. (2003) (2)
Improvement of Therapy Results in Treatment of Port Wine Stains with the Argonlaser (1988) (2)
[Malignant melanomas in pregnancy]. (1985) (2)
Rosai-Dorfman disease with cutaneous manifestation (sinus histiocytosis with massive lymphadenopathy). (2006) (2)
[Smoking -- effects on the skin]. (2003) (2)
[Use of phytopharmaceutical agents in dermatology. Indications, therapeutic approaches and side effects]. (2005) (2)
Intravenous injection of indocyanine green to enhance laser‐assisted coagulation of blood vessels in skin – an animal study (2013) (2)
[Adjuvant therapy of melanoma patients with gamma interferon]. (1987) (2)
[The dysplastic nevus. Separate entity, melanoma precursor or diagnostic dilemma?]. (2003) (1)
[Treatment of therapy refractory verrucae vulgares with a ciclopirox-containing lacquer]. (2001) (1)
[Ofuji papuloerythroderma: PUVA bath treatment]. (1999) (1)
Laser treatment of port wine stains. (1987) (1)
Differential Gene Expression of Eph Receptors and Ephrins in Various Benign Human Tissues and Cancers (2004) (1)
Chemical Analysis of Tattoo Pigments Cleaved by Laser Light (2007) (1)
Granulomatöse Dermatitis nach Quallenkontakt (2007) (1)
Possibilities for the Increase of the Coagulation Depth in Skin with the Argonlaser (1988) (1)
[The interdisciplinary aspects of notalgia paraesthetica]. (1994) (1)
Successful treatment of granuloma annulare with a topically applied vitamin E emulsion: A retrospective study (1998) (1)
[Spindle cell lipoma]. (1989) (1)
Nd: YAG Laser Therapy of Teleangiectasias (1986) (1)
Mysterious disappearance of an allogenic anterior cruciate ligament graft – a case of allergy against altered collagen (2006) (1)
The Spectrum of Photodamage and its Treatment (1995) (1)
Topical photodynamic therapy with 5-aminolevulinic acid for actinic keratoses using the sclerolaser® at 585 NM (1998) (1)
9-acetoxy-2,7,12,17-tetrakis-(B-methoxyethyl)- porphycene (ATMPn): a novel photosensitizer for photodynamic therapy--dose-dependent effects in vitro (1996) (1)
Laser Treatment of Benign, Premalignant, and Malignant Neoplasms of the Oral Mucosa (1986) (1)
Efficacy of Nd:YAG laser treatment (1064 nm) of leg veins depends on the vessel diameter (2008) (1)
Therapeutic possibilities in actinic reticuloid (1993) (1)
A woman with a dangling digit (2007) (1)
Erythema scarlatiniforme desquamativum generalisatum (2013) (1)
Year : 2010 Cyclooxygenase 2 ( COX 2 ) and peroxisome proliferator-activated receptor gamma ( PPARG ) are stage-dependent prognostic markers of malignant melanoma (2010) (1)
[p16(INK4A)/CDKN2--the "melanoma gene"? Status of research and outlook]. (1998) (1)
[How large is the loss of effectiveness of a treatment procedure between "theory" and "practice"? Evaluating health economics basic data within the scope of a trial model of ambulatory synchronous balenophototherapy of atopic eczema]. (2002) (1)
[Skin aging]. (2009) (1)
[Malignant melanoma, leukoderma and vitiligo]. (1980) (1)
[Radioimmunoscintigraphy with monoclonal antibodies]. (1987) (1)
New Light Guide with a Sapphire Tip for the Argon Laser (1988) (1)
[Condylomata acuminata gigantea (Buschke-Löwenstein tumor). Treatment with the CO2 laser and interferon]. (1988) (1)
[Dialysis associated skin changes]. (2004) (1)
[Profiling methods in dermatology]. (2005) (1)
[Lasers in dermatology--what they can really accomplish]. (1999) (1)
Fluorescence diagnosis of skin tumors following topical application of 5-aminolevulinic acid (1998) (1)
Initial acro-osteolysis ulcero-mutilans in two brothers with hereditary type I motor sensory neuropathy (1996) (1)
Patients’ Confidence in Dermoscopical Methods for Detection of Malignant Melanoma (2002) (1)
[Psoriatic onycho-pachydermo- periostitis]. (2002) (1)
Multiple, bilateral and painful ear nodules of the anthelices: a variant of chondrodermatitis nodularis? (2002) (1)
Autoradiographic and planimetric analyses of the inflammatory infiltrate in psoriatic lesions under PUVA-therapy (2004) (1)
Lasers and Energy Sources for Skin Rejuvenation and Epilation (2007) (1)
[Laser technology in dermatology: quo vadis--science or business?]. (1998) (1)
Cooling Devices in Laser Therapy (2001) (1)
[Malignant melanoma of the penis]. (1990) (1)
[Nocardia farcinica infection of a vascular prosthesis]. (2007) (1)
Systemic mastocytosis associated with cutaneous B‐cell lymphoma (2013) (1)
[Long-term course of necrobiotic xanthogranuloma with ocular involvement]. (2006) (1)
[Unusual primary cutaneous localized amyloidosis]. (1990) (1)
[Skin and alcohol]. (2005) (1)
[Classification, diagnosis and differential diagnosis of malignant melanoma]. (1994) (1)
[Minocycline-induced hyperpigmentation]. (1998) (1)
Experience with the early treatment of childhood haemangiomata using the flashlamp-pumped dye laser (1996) (1)
Induction of interstitial collagenase by UVA-1 phototherapy in fibroblastic cells of morphea (1998) (1)
Indocyanine green-augmented diode laser therapy of telangiectatic and reticular leg veins: a clinical proof-of-concept trial (2012) (1)
9-acetoxy-2,7,12,17-tetrakis-(B-methoxyethyl)- porphycene (ATMPn): a novel photosensitizer for photodynamic therapy--intracellular uptake and distribution in vitro (1996) (1)
[Therapy and prognosis of malignant melanoma of the skin]. (1986) (1)
Prevalence of piercing in a German populationPetra (2008) (0)
Skin Resurfacing — CO2-Lasertechniken versus Er:YAG-Laser (1999) (0)
Dermatology in South Africa-Reply (1995) (0)
Unusual Cases Treated with the CO2-Laser (1990) (0)
Lasers and Photodynamic Therapy (2009) (0)
[New aspects of food allergy]. (1996) (0)
11.4 Therapie kutaner B-Zell-Lymphome (Cutaneous B-Cell Lymphoma, CBCL) (2010) (0)
Effects of Laserlight of Low Power Density on Sebaceous Glands (1988) (0)
Plasmocytoma-Induced Intertriginous Amyloid Purpura (2013) (0)
[Side effects of drugs on the salivary glands and mouth mucosa]. (1986) (0)
[Pigment demarcation lines in pregnancy]. (1986) (0)
[Skin and eyes]. (2009) (0)
[Type I pachyonychia congenita (Jadarssohn-Lewandowsky)]. (1999) (0)
Improvement of all clinical stages of morphea (localized scleroderma) after ultraviolet A-1 phototherapy (1998) (0)
[Is the argon laser contraindicated in the summer?]. (1993) (0)
[A pleading for the DDA]. (2003) (0)
[Acne comedonica following radiation therapy]. (1998) (0)
Malignant melanoma cells in zones of proliferation express higher telomerase activity than central cells of the tumor (1998) (0)
[Positive tuberculin reaction in sarcoidosis]. (1995) (0)
Band 1, Heft 3, September 2000 (2000) (0)
Dose-dependent Photodynamic Effects of 9-A ceto xy-2,7,12,17-tet ra ki s-(p- m et h o xyet hy I)- porphycene In Vitro (1997) (0)
Arbitrarily primed PCR: A novel technique for monitoring of genetic defects during melanoma progression (1994) (0)
High-power argon laser treatment for port-wine stains: Clinical and histological results (1993) (0)
METASTATIC MELANOMA WITH SIGNET-RING CELL APPEARANCE - EVIDENCE OF DIVERGENT HISTOMORPHOLOGIC TUMOR CELL DIFFERENTIATION IN A PATIENT WITH UNKNOWN PRIMARY (1992) (0)
[Colloid milium]. (1990) (0)
Stroma‐orientierte palliative Tumortherapie mit Biomodulatoren (2006) (0)
Band 3, Heft 3, September 2002 (2002) (0)
RNA fingerprinting displays transcriptional disruption in human melanomas selected for multicytokine-resistance in athymic nude mice (1998) (0)
Wavelength-dependent photodynamic inactivation of HaCaT human keratinocytes after preincubation with 5-aminolevulinic acid (1994) (0)
6.4 Interleukin 2 (IL-2) (2010) (0)
Comparison of Erbium:YAG and Carbon Dioxide Laser for the Treatment of Facial Rhytides. (1999) (0)
Malignant Melanoma Versus Deep Penetrating Nevus: Diagnostic and Prognostic Immunohistochemistry of Dipeptidyl Peptidase IV (Methodology) (2010) (0)
Specific detection of melanoma cells in the blood by MIA RT-PCR (1998) (0)
Morphologic Effects of Short Argon and Dye Laser Pulses (1988) (0)
Leserbriefe (2007) (0)
Effects of photodynamic treatment on contraction of collagen gels by cultured human dermal fibroblasts (1994) (0)
Enhanced PDT effect in patients with esophageal cancer by laser light fractionation—A pilot study (1996) (0)
ILDS Newsletter No. 23 (2012) (0)
Degree of Actinic Elastosis Is a Surrogate of Exposure to Chronic Ultraviolet Radiation and Correlates More Strongly with Cutaneous Squamous Cell Carcinoma than Basal Cell Carcinoma (2023) (0)
Indocyanine Green: Phototoxic Effects in vitro (1998) (0)
Re-expression of Dipeptidylpeptidase 4 (DPP4) in melanoma cells – insights into molecular consequences (2004) (0)
[Pretibial purpura in a 60-year-old football player]. (2006) (0)
6.3 Interferone (2010) (0)
[Therapeutic use of lasers in dermatology]. (1999) (0)
Ionizing Radiation/X-Ray Therapy (1988) (0)
[Correct indications for laser treatment of skin diseases]. (2006) (0)
DivergentBRAFmutation status of matched primary tumours and metastases in melanoma patients (2011) (0)
5.3 Retinoide (2010) (0)
Newsletter ILDS No 15 (2010) (0)
[Verruciform xanthoma. Presentation of a case and review of the literature]. (1989) (0)
New light source for PDT of skin lesions (1994) (0)
FC074 A CD-rom based program for clinical dermatology: Applications (1997) (0)
XXXI. Annual Meeting of the ADF (2004) (0)
Increased expression of aminopeptidase N (APN, CD13) and neutral endopeptidase (NEP, CD10) in primary malignant melanoma (1998) (0)
[Laser treatment of nevus cell nevi in the newborn infant]. (1999) (0)
Lasers: Biological Effects and Therapy (1988) (0)
Expression of cyclooxygenase-2 (COX-2) and peroxisome proliferator-activated receptor gamma (PPARγ) in skin tumors (2007) (0)
77th Annual Meeting of the Swiss Society for Dermatology and Venereology (1995) (0)
Laser-induced stimulation of sperm motility in vitro (1984) (0)
Dermabrasion Versus CO 2 Laser in the Removal of Tattoos — A Comparative Study (1988) (0)
Indocyanine greenandlaserlight forthetreatmentof AIDS-associated cutaneousKaposi's sarcoma (1998) (0)
979 Antiangiogenetic therapy with pioglitazone, rofecoxib and metronomic trofosfamide in advanced malignant vascular tumors (2003) (0)
Effects of Mometasone Furoate on 09 Human Keratinocytes and 10 Fibroblasts in vitro 12 (1998) (0)
Aggregation of melanocytic nevi on the paralyzed leg of a patient with poliomyelitis. (2011) (0)
[Initial experiences with the neodym-YAG laser treatment of metastasizing skin tumors]. (1983) (0)
Newsletter No. 8/2009 (2009) (0)
Isoliertes Steatocystoma Multiplex des Capillitiums (1995) (0)
A rare allergy to a polyether dental impression material (2011) (0)
Successful Treatment of Hailey-Hailey Disease with a Scanned Carbon Dioxide Laser (1999) (0)
Comparative Investigation of Tissue Reaction with 1.06 µm and 1.32 µm Nd: YAG Laser Radiation (1986) (0)
Targeting of the microvasculature of solid tumors by ICG-mediated phototherapy (1998) (0)
[CO(2) laser vaporisation of actinic cheilitis]. (1999) (0)
New Laser Literature (2004) (0)
High prognostic significance of P53 protein and K167 expression in thick malignant melanomas (1994) (0)
Practical aspects of topical PDT (2006) (0)
[Skin melanomas of the head and neck: therapeutic value of cervical lymphatic dissection]. (1992) (0)
[Hydroa vacciniforme]. (2020) (0)
S019 Strawberry nevi — To treat or not to treat? (1997) (0)
Early Recurrence of Eruptive Vellus Hair Cysts after Er: YAG Laser Therapy (2005) (0)
Argon Laser Therapy of Port Wine Stains — Statistical Analysis (1986) (0)
[Skin changes and anorexia nervosa]. (2007) (0)
[Laser therapy of skin changes in the face and mouth mucosa]. (1993) (0)
[Skin and teeth]. (2009) (0)
A multivarite model for differentiation of Spitz nevu and malignant melanomas using digital image cytometry (1994) (0)
Significant correlations between DNA cytometry and histologic criteria for prognosis of malignant melanoma (1993) (0)
[Complications and undesired effects in aesthetic dermatology]. (2013) (0)
[Epidermolysis bullosa hereditaria dystrophica (Hallopeau-Siemens). Case report and therapy trial with (+)-cyanidanol-3 in 3 patients]. (1987) (0)
P73, the new p53 homologue, is not involved in the pathogenesis of cutaneous malignant melanomas (1998) (0)
Phototherapy‐induced elevation of serum level of melanoma inhibitory activity (2019) (0)
Method and apparatus for capturing and editing pictures biological tissue (1997) (0)
Image analysis in skin cancer recognition (1996) (0)
[Argon and Nd-YAG laser in the treatment of hemangiomas]. (1987) (0)
2D Luminescence Imaging of Wound pH (2011) (0)
[Purpura through liver damage]. (1978) (0)
Graft-versus-Host-Disease (GvHD) – ein Update (2011) (0)
Two-Dimensional Luminescence Imaging of Physiological Wound Oxygenation (2011) (0)
Newsletter No. 5/2009 (2008) (0)
Subject Index Vol. 194, 1997 (1997) (0)
Newsletter ILDS No. 13 (2010) (0)
Lasers in dermatology: proceedings of the international symposium, Ulm, 26 September 1989 (1991) (0)
[Excimer laser (308 nm) - a new option in dermatologic UVB therapy]. (2003) (0)
Acknowledgment to Referees for Dermatology 1998 (1998) (0)
[Tufted angioma]. (2001) (0)
Contents, Vol. 194, 1997 (1997) (0)
Lasers: applications for skin cancer. New modalities in techniques (1993) (0)
Black tattoo inks in skin—A hazardous chemical cocktail? (2011) (0)
In vitro photodynamic effects of Dimegin (2,4-Di-(α-methoxyethyl)-deuteroporphyrin IX): Uptake, localization and cell survival (1998) (0)
Photodynamic therapy of skin diseases (1998) (0)
[Possibilities for tattoo removal. Report of experiences]. (1982) (0)
Poster (2016) (0)
Photodynamic Therapy of Skin Cancers: A New Therapeutic Alternative? (1996) (0)
11.2 Pseudolymphome (2010) (0)
[Argon laser in rosacea]. (1993) (0)
Topical photodynamic therapy with 5-ALA in the treatment of arsenic-induced skin tumors (1994) (0)
Lasertherapy of Disseminated Kaposi’s Sarcoma (DKS) (1990) (0)
13.2 Obligate kutane Paraneoplasien (2010) (0)
An Infant with a Nevus Depigmentosus: Disorders with Impaired Pigmentation (2009) (0)
Clinical results of total skin electron-beam radiation therapy for cutaneous T-cell lymphoma in advanced stages (1993) (0)
[Laser skin resurfacing. Er:YAG laser and cw-CO2 laser with scanner system in direct comparison]. (1998) (0)
[Multiple mucous and conjunctival nodules in a 16-year old patient]. (2012) (0)
[Laser therapy of dermatologic diseases]. (1992) (0)
New developments and technologies in dermatology (2007) (0)
Laser and Photodynamic Therapy (2020) (0)
6.7 Antiangiogenese (2010) (0)
C070 Photodynamic therapy (1997) (0)
[Hemorrhagic dengue fever after trip to Malaysia]. (2006) (0)
14.3 Kutane Lymphome (2010) (0)
Introduction to lasers in dermatology (1995) (0)
[Is the argon laser contraindicated in childhood?]. (1993) (0)
[Pigmented urticarial erythema with flaccid atrophy as expression of an unusual manifestation of Lyme borreliosis]. (1992) (0)
[Treatment of stage I malignant melanoma. Open questions and recommendations]. (1989) (0)
[Cryoglobulinemia in plasmocytoma]. (1980) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Míchael Landthaler?

Míchael Landthaler is affiliated with the following schools:

University of Regensburg

Míchael Landthaler's Academic­Influence.com Rankings

Why Is Míchael Landthaler Influential?

Míchael Landthaler's Published Works

Published Works

What Schools Are Affiliated With Míchael Landthaler?

Míchael Landthaler's AcademicInfluence.com Rankings